Features of cytokine status of the newborns with seizures

Cover Page

Cite item

Full Text

Abstract

The aim of the present study was to assess the level of cytokines in newborn children of various gestational terms with seizures. A prospective, comprehensive study of 307 newborns of various gestational ages with seizures was carried out.

Evaluation of anamnestic data, antenatal, intrapartum risk factors with using statistical methods showed that mothers of newborns (respectively, full-term and premature) with seizures had a high percentage of extragenital diseases (31.8±3.7% χ2 = 15.4, p = 0.009, vs 62.3±5.0% χ2 = 27.2, p1 < 0.001), gynecological disorders (49.1±3.6% χ2 = 37.1 p < 0.001, and 47.0±5.1% χ2 = 9.69 p1 = 0.046), threatened miscarriage (9.1±2.5% χ2 = 11.290 p < 0.001, and 28.5±4.7% χ2 = 14.779 p1 < 0.001), anemia of pregnancy (40.0±3.6% χ2 = 14.9 , p < 0.001 vs 66.4±4.3% χ2 = 18.9, p < 0.001). After EEG examination, we found that in most cases, 78 (30.0%) newborns exhibited polymorphic convulsions, i.e. a combination of different types of convulsions. The atypical convulsions were reported in 64 (24.5%) newborns, with a predominance of preterm infants 61 (40.4%). Clonic seizures were more common in full-term infants (n = 34; 30.9%) and preterm (n = 26; 17.2%). Myoclonic convulsions were found mainly in preterm newborns 21% (13.9%). Tonic convulsions were found in only 5 cases (5.3%). According to neurosonographic data, brain swelling was reported in 83 (31.8%), ventriculomegaly in 44 (16.9%), ventriculitis in 43 (16.5%), intraventricular hemorrhage in 66 (15.3%) newborns of the main group. In the control group, periventricular hemorrhage was observed in 37 (14.2%) newborns. Frequency of these disorders in preterm infants was 18.6% higher than in full-term infants (χ2 = 13.3; p = 0.004). Altered immunological reactivity in newborns with seizures manifested as abnormal cytokine status and significantly elevated pro-inflammatory cytokines (IL-1β, 1.9-fold; IL-6, 3-fold; TNFα 3.3-fold increase) compared with newborns of control group. Increased concentration of pro-inflammatory cytokines in newborns with HIE is associated with maintenance of seizure activity and aggravates further unfavorable neurological outcome. The cerebral disorders and dysfunction of different organs and systems were found to correlate with immune parameters. Hence, the expression of pro-inflammatory cytokines may be used as a screening marker in diagnostics and prediction of neonatal seizures in presence of perinatal hypoxic-ischemic lesions of the central nervous system.

About the authors

G. M. Gurbanova

K. Farajova Research Institute of Pediatrics

Email: rahimova_nailya@mail.ru

PhD (Medicine), Assistant Professor, Department of Neurology

Azerbaijan, 1065, Baku, Basti Bagirova str., 17

Naila J. qızı Ragimova

A. Aliyev Azerbaijan State Medical Institute for Postgraduate Education

Author for correspondence.
Email: rahimova_nailya@mail.ru

PhD, MD (Medicine), Associate Professor, Deputy Director for Research

Azerbaijan, 1065, Baku, Basti Bagirova str., 17

References

  1. Айкарди Ж., Бакс М., Гиллберг К. Заболевания нервной системы у детей. Пер. с англ.; под ред. А.А. Скоромца. М., 2013. 1036 с. [Aikardi J., Bax M., Gillberg K. Diseases of the nervous system in children (Translated from English under the editorship of A.A. Skoromets)]. Moscow, 2013. 1036 p.
  2. Галашева З.В., Поскотинова Л.В. Роль интерлейкина-6 и интерлейкина-10 в функционировании НС // Вестник САФУ. Сер.: Медико-биологические науки, 2016. № 3. С. 5-17. [Galasheva Z.V., Poskotinova L.V. The role of interleukin-6 and interleukin-10 in the nervous system function at the early and mature stages of ontogeny. Vestnik SAFU. Ser.: Mediko-biologicheskie nauki = Bulletin of the Northern (Arctic) Federal University. Biomedical Sciences, 2016, no. 3, pp. 5-17. (In Russ.)]
  3. Гараев В.Р., Скоромец А.П., Шумилина М.В., Горелик Ю.В., Мостовой А.В., Любименко В.А., Шабалов В.П., Каган А.В. Новые возможности терапии детей, родившихся в состоянии асфиксии, и предикторы их неврологического исхода // Нейрохирургия и неврология детского возраста, 2012. Т. 31, № 1. С. 79- 83. [Garaev V.R., Skoromets A.P., Shumilina M.V., Gorelik Yu.V., Mostovoy A.V., Lyubimenko V.A., Shabalov V.P., Kagan A.V. New possibilities of therapy for children born with asphyxia and predictors of their neurological outcome. Neyrokhirurgiya i nevrologiya detskogo vozrasta = Pediatric Neurosurgery and Neurology, 2012, Vol. 31, no. 1, pp. 79-83. (In Russ.)]
  4. Карпова Л.Н., Таранушенко Т.Е., Салмина А.Б. Клинико-метаболические особенности церебральной ишемии у доношенных новорожденных с анемией // Педиатрия, 2011. Т. 90, № 1. С. 23-29. [Karpova L.N., Taranushenko T.E., Salmina A.B. Clinical and metabolic features of cerebral ischemia in term infants with anemia. Pediatriya = Russian Pediatrics, 2011, Vol. 90, № 1, pp. 23-29. (In Russ.)]
  5. Панченко А.С., Панова М.С. Биохимические маркеры гипоксического поражения головного мозга у доношенных новорожденных // Доктор.Ру, 2020. Т.19, № 3. C. 12-16. [Panchenko A.S., Panova M.S. Biochemical markers of hypoxic brain damage in full-term newborns. Doktor.Ru = Doctor.Ru, 2020, Vol. 19, no. 3, pp. 12-16. (In Russ.)]
  6. Рагимова Н.Д., Гурбанова Г.М. Нейроиммунологические нарушения у недоношенных детей с перинатальными инфекциями // Педиатрическая фармакология, 2018. Т. 15, № 1. С. 95-101. [Rahimova N.J., Gurbanova G.M. Neuroimmunological disturbance features in premature infants with perinatal infections. Pediatricheskaya farmakologiya = Pediatric Pharmacology, 2018, Vol. 15, no. 1, pp. 95-101. (In Russ.)]
  7. Созаева Д.И., Бережанская С.Б. Основные механизмы взаимодействия нервной и иммунной систем. Клинико-экспериментальные данные // Кубанский научный медицинский вестник, 2014. № 3 (145). С. 145-150. [Sozaeva D.I., Berezhanskay S.B. The basic mechanisms of interaction nervous and immune systems. Clinico-experimental data. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin, 2014, no. 3 (145), pp. 145-150. (In Russ.)]
  8. Чистякова Г.Н., Ремизова И.И., Газиева И.А., Бычкова С.В., Занина Е.В., Чарипова Б.Т. Про- и противовоспалительные медиаторы у новорожденных с перинатальной патологией // Российский вестник перинатологии и педиатрии, 2014. Т. 59, № 2. С. 66-70. [Chistyakova G.N., Remizova I.I., Gazieva I.A., Bychkova S.V., Zanina E.V., Charipova B.T. Pro- and anti-inflammatory mediators in neonates with perinatal pathology. Rossiyskiy vestnik perinatologii i pediatrii = Russian Bulletin of Perinatology and Pediatrics, 2014, Vol. 59, no. 2, pp. 66-70. (In Russ.)]
  9. Aly H., Khashaba M.T., El Ayouty M., El Sayed O., Hasanein B.M. IL-1 beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev., 2006, Vol. 28, no. 3, pp. 178-182.
  10. Arimoto T., Choi D.-Y., Lu X., Liu M., Nguyen X.V., Zheng N., Stewart C.A., Kim H.-C., Bing G. Interleukin 10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol. Aging., 2007, Vol. 28, no. 6, рр. 894-906.
  11. Boylan G., Stevenson N., Vabhatalo S. Monitoring neonatal seizures. Semin. Fetal Neonatal Med., 2013, Vol. 18, no. 4, рр. 202-208.
  12. Garg P.R., Saraswathy K.N., Kalla A.K., Sinha E., Ghosh P.K. Pro-inflammatory cytokine gene polymorphisms and threat for coronary heart disease in a North Indian Agrawal population. Gene, 2013, Vol. 514, no. 1, pp. 69-74.
  13. Glass H. Neonatal seizures: advances in mechanisms and management. Clin. Perinatol., 2014, Vol. 41, no. 1, рр. 177-190.
  14. Glass H.C., Shellhaas R.A., Wusthoff C.J., Chang T., Abend N.S., Chu C.J., Cilio M.R., Glidden D.V., Bonifacio S.L., Massey S., Tsuchida T.N., Silverstein F.S., Soul J.S., Neonatal Seizure Registry Study Group. Contemporary profile of seizures in neonates: A prospective cohort study. J. Pediatr., 2016, Vol. 174, рр. 98-103.
  15. Hart A., Pilling E., Alix J. Neonatal seizures – part 1: Not everything that jerks, stiffens and shakes is a fit. Arch. Dis. Child Educ. Pract. Ed., 2015, Vol. 100, рр. 170-175.
  16. Hermandez-Ontiveros D.G., Tajiri N., Acosta S., Giunta B., Tan J., Borlongan C.V. Microglia activation as a biomarker for traumatic brain injury. Front. Neurol., 2013, Vol. 4, 30. doi: 10.3389/fneur.2013.00030.
  17. Jensen F., Silverstein F. Neonatal seizures. In: Swaiman’s Pediatric Neurology: Principles and Practice 5th edition [Internet]. In: Swaiman K., Ashwal S., Ferriero D.M., N.F. S., editors. Edinburgh: Elsevier; 2012 [Cited 2016 Aug 15]. Available from: ClinicalKey Australia.
  18. Lisyany N.I., Znamenska T.K., Martyniuk V.Yu., Shveikina V.B. To the question of neuroimmune mechanisms in the formation of perinatal brain damage. Modern Pediatrics. Ukraine, 2019, Vol. 6, no. 102, 7289. doi: 10.15574/SP.2019.102.72.
  19. Rao S., Lewis B., Ghosh S., Nagarajan L. Clinical approach to neonatal seizures. In: Nagarajan L., editor. Neonatal seizures: current treatment and future challenges. London: Mac Keith Press, 2016.
  20. Sävman K., Blennow M., Hagberg H., Tarkowski E., Thoresen M., Whitelaw A. Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta Paediatr., 2007, Vol. 91, no. 12, рр. 1357-1363.
  21. Sivaswamy L. Approach to neonatal seizures. Clin. Pediatr. (Phila), 2012, Vol. 51, no. 5, рр. 415-425.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Gurbanova G.M., Ragimova N.J.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies